These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 7181567)

  • 1. [Value of apolipoprotein B determination in evaluation of atherogenic risk].
    Messaoudia Y
    Arch Inst Pasteur Tunis; 1982 Mar; 59(1):217-20. PubMed ID: 7181567
    [No Abstract]   [Full Text] [Related]  

  • 2. [Differential use of apolipoproteins and lipoproteins as discriminators for atherogenic risk].
    Mertz DP; Göhmann E; Ostertag J
    Med Welt; 1981 Oct; 32(43):1611-5. PubMed ID: 7300661
    [No Abstract]   [Full Text] [Related]  

  • 3. [The use of apolipoprotein B in clinical practice to determine the risk for atherosclerosis].
    Cabezas Castro M; Liem A
    Ned Tijdschr Geneeskd; 2003 Jul; 147(30):1445-8. PubMed ID: 12908345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apolipoproteins--important discriminators for atherosclerotic vascular disease.
    Mordasini R; Riesen WF
    Monogr Atheroscler; 1986; 14():145-9. PubMed ID: 3736553
    [No Abstract]   [Full Text] [Related]  

  • 5. [Molecular analysis of atherogenic and protective lipoproteins].
    Fruchart JC; Bard JM; Fievet C; Puchois P
    Arch Mal Coeur Vaiss; 1987 Sep; 80 Spec No():13-6. PubMed ID: 2445318
    [No Abstract]   [Full Text] [Related]  

  • 6. Atherogenic lipoprotein constellation.
    Mordasini R; Riesen WF
    Horm Metab Res Suppl; 1988; 19():16-8. PubMed ID: 3069689
    [No Abstract]   [Full Text] [Related]  

  • 7. Subendothelial retention of atherogenic lipoproteins in early atherosclerosis.
    Skålén K; Gustafsson M; Rydberg EK; Hultén LM; Wiklund O; Innerarity TL; Borén J
    Nature; 2002 Jun; 417(6890):750-4. PubMed ID: 12066187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [ Lipids--lipoproteins--apolipoproteins--risk markers in atherosclerosis].
    Slimane MN; Bouslama A; Maatoug F; Hammami M; Ben Farhat MH
    Tunis Med; 1992 Feb; 70(2):91-6. PubMed ID: 1496741
    [No Abstract]   [Full Text] [Related]  

  • 9. Apolipoproteins: significance for lipid metabolism and for diagnosis of atherosclerotic disease.
    Kostner GM; Wurm H; Zechner R; Pilger E; Dieplinger H
    Prog Clin Biol Res; 1985; 188():67-77. PubMed ID: 4059260
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of antiatherogenic L-aspartate and L-glutamate on serum lipoproteins cholesterol and apolipoproteins A-1 and B in rabbits fed with high cholesterol diet.
    Yanni AE; Perrea DN; Yatzidis HA
    Nutr Metab Cardiovasc Dis; 2005 Jun; 15(3):161-5. PubMed ID: 15955463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-density lipoprotein, non-high-density lipoprotein, and apolipoprotein B as targets of lipid-lowering therapy.
    Feeman WE
    Circulation; 2003 May; 107(20):e199. PubMed ID: 12777330
    [No Abstract]   [Full Text] [Related]  

  • 12. [A simple procedure for the simultaneous determination of apolipoproteins AI and B using rocket immunoelectrophoresis].
    Oswald B; Winkler L; Schlag B; Dargel R
    Z Med Lab Diagn; 1984; 25(8):411-6. PubMed ID: 6441367
    [No Abstract]   [Full Text] [Related]  

  • 13. Measurement of apoproteins: time to improve the diagnosis and treatment of the atherogenic dyslipoproteinemias.
    Sniderman AD; Cianflone K
    Clin Chem; 1996 Apr; 42(4):489-91. PubMed ID: 8605661
    [No Abstract]   [Full Text] [Related]  

  • 14. [Plasma apolipoproteins: their role in cardiovascular diseases and usefulness of their blood concentration determination. Committee of the Study of Apolipoproteins, Italian Heart Foundation].
    Cardiologia; 1997 Feb; 42 Suppl 1():1-39. PubMed ID: 9147845
    [No Abstract]   [Full Text] [Related]  

  • 15. [Apolipoproteins as risk factors of atherosclerosis].
    Dargel R; Winkler L
    Z Med Lab Diagn; 1989; 30(1):35-6. PubMed ID: 2718575
    [No Abstract]   [Full Text] [Related]  

  • 16. [The determination of apolipoproteins. Its possible diagnostic importance].
    Titov VN; Tvorogova MG
    Ter Arkh; 1992; 64(6):115-9. PubMed ID: 1440326
    [No Abstract]   [Full Text] [Related]  

  • 17. Apolipoprotein B: a clinically important apolipoprotein which assembles atherogenic lipoproteins and promotes the development of atherosclerosis.
    Olofsson SO; Borèn J
    J Intern Med; 2005 Nov; 258(5):395-410. PubMed ID: 16238675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-dialysis retention of blood lipoproteins and apolipoproteins in patients with end-stage renal disease on maintenance haemodialysis in Kuwait.
    Al-Rashidi M; Hussain AA; Nampoory MR; Al-Ali JH; Akanji AO
    Clin Chim Acta; 2004 Jun; 344(1-2):149-54. PubMed ID: 15149883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Isolation and immunologic determination of apolipoprotein A-I in human serum].
    Eichhorn D; Denisenko AD; Trübsbach A; Gehrisch S; Jaross W
    Z Med Lab Diagn; 1983; 24(8):438-44. PubMed ID: 6424350
    [No Abstract]   [Full Text] [Related]  

  • 20. Cardiovascular biology: a cholesterol tether.
    Staels B
    Nature; 2002 Jun; 417(6890):699-701. PubMed ID: 12066168
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.